文献速递妇科

铒钇铝石榴石阴道激光治疗女性压力性尿失禁的双盲随机对照试验

Double-blind randomized controlled trial of Er: YAG vaginal laser to treat female stress urinary incontinence.
PubMed 文献 · Am J Obstet Gynecol · 2024-11-26

这项双盲随机假对照试验在单中心纳入144例有症状的女性压力性尿失禁患者,比较铒钇铝石榴石阴道激光与假治疗的疗效。治疗6个月后,两组在主要结局(主观报告无尿失禁)上无差异,激光组为0.0136(95%CI 0.0006-0.0811),假治疗组为0.0000(95%CI 0.0000-0.0666)。结论认为激光并不比假治疗更有效。

要点

  • 治疗6个月后,激光组与假治疗组在主观报告无尿失禁的治愈率上无差异。
  • 仅在治疗6周后,3份尿失禁问卷中的1份及生活质量问卷9个领域中的3个出现统计学显著差异。
  • 6周和6个月时,其余主观及客观指标在两组间均无显著差异。

核心结论

  • 铒钇铝石榴石激光在治愈或改善女性压力性尿失禁方面并不比假治疗更有效(6个月时)。

研究设计与样本

  • 双盲随机假对照试验,在单中心三级医院开展,纳入144例有症状的女性压力性尿失禁成年患者,随机分为激光组76例和假治疗组68例。
  • 每位参与者接受2次阴道激光治疗,间隔6周,随访6周和6个月。
  • 主要结局为治疗6个月后国际尿失禁咨询问卷简表第3题主观报告无尿失禁。

主要发现

  • 治疗6个月后,两组报告治愈率(主要结局)无差异:激光组0.0136(95%CI 0.0006-0.0811),假治疗组0.0000(95%CI 0.0000-0.0666)。
  • 治疗6周后,3份尿失禁问卷中的1份及生活质量问卷9个领域中的3个出现统计学显著差异。
  • 治疗6周和6个月时,其余主观或客观指标在两组间均无其他显著差异。

关键数值与推荐

  • 主要结局治愈率:激光组0.0136(95%CI 0.0006-0.0811)vs 假治疗组0.0000(95%CI 0.0000-0.0666),两组无差异。
  • 治疗6周后,3份尿失禁问卷中的1份和9个生活质量领域中的3个有统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stress urinary incontinence affects approximately 40% of adult females and is often treated surgically. Minimally invasive vaginal laser therapy to treat stress urinary incontinence has become widely available, but the efficacy of this novel therapy is unclear. OBJECTIVE: This study aimed to determine the efficacy of erbium-doped yttrium aluminum garnet laser as a therapy for stress urinary incontinence. STUDY DESIGN: This was a double-blind randomized sham-controlled trial with 6-week and 6-month follow-ups at a single tertiary hospital setting with 144 adult female patients with symptomatic stress urinary incontinence. Each participant received 2 vaginal laser therapies 6 weeks apart, with patients randomized to either laser or sham. The primary outcome was patients' subjective reporting of no urinary incontinence at 6 months after treatment on question 3 of the International Consultation on Incontinence Questionnaire-Short Form. The secondary outcomes included objective measures of urine loss with 24-hour pad tests, 3 incontinence symptom questionnaires (Urogenital Distress Inventory-6, Incontinence Impact Questionnaire-7, and International Consultation on Incontinence Questionnaire-Short Form), 1 quality-of-life questionnaire (King's Health Questionnaire), and 1 sexual function questionnaire (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire). RESULTS: Of 263 individuals approached, 76 of 144 individuals were randomized to the laser treatment group, and 68 of 144 individuals were randomized to the sham treatment group. There was no difference in the reported cure rate and the primary outcome at 6 months after treatment between the groups (laser treatment group: 0.0136; 95% confidence interval, 0.0006-0.0811; sham treatment group: 0.0000; 95% confidence interval, 0.0000-0.0666). Apart from a statistically significant difference noted at 6 weeks after treatment in 1 of 3 incontinence questionnaires and 3 of 9 domains of the quality-of-life questionnaire, there were no other significant differences in our subjective or objective measures between the 2 groups at 6 weeks and 6 months after treatment. CONCLUSION: Er: YAG laser was no more effective than sham for curing or improving female stress urinary incontinence at 6 months.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee P, Perruzza D, Edell H, et al. Double-blind randomized controlled trial of Er: YAG vaginal laser to treat female stress urinary incontinence. Am J Obstet Gynecol. 2024. PMID: 39603442. doi:10.1016/j.ajog.2024.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。